1.
Siegel D, Murphy C, Wangsness K, Perry A, Smith I. Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma. J of Skin [Internet]. 2022Mar.4 [cited 2022Aug.18];6(2):109-21. Available from: https://jofskin.org/index.php/skin/article/view/1475